In the last trading session, 1.21 million shares of the Outset Medical Inc (NASDAQ:OM) were traded, and its beta was 2.00. Most recently the company’s share price was $0.73, and it changed around $0.0 or 0.04% from the last close, which brings the market valuation of the company to $39.08M. OM currently trades at a discount to its 52-week high of $5.22, offering almost -615.07% off that amount. The share price’s 52-week low was $0.44, which indicates that the current value has risen by an impressive 39.73% since then.
Outset Medical Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended OM as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Outset Medical Inc is expected to report earnings per share of -0.26 for the current quarter.
Outset Medical Inc (NASDAQ:OM) trade information
Instantly OM has showed a green trend with a performance of 0.04% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9000 on recent trading dayincreased the stock’s daily price by 18.89%. The company’s shares are currently down -34.44% year-to-date, but still down -16.87% over the last five days. On the other hand, Outset Medical Inc (NASDAQ:OM) is -11.26% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 87.83% from its current value. Analyst projections state that OM is forecast to be at a low of $3 and a high of $34.
Outset Medical Inc (OM) estimates and forecasts
The year-over-year growth rate is expected to be 5.78%, up from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 27.81M in revenue for the current quarter. 5 analysts expect Outset Medical Inc to make 29.14M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 28.17M and 27.39M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -1.26%. Forecasts for the next quarter put sales growth at 6.39%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -4.06%. Outset Medical Inc earnings are expected to increase by 42.57% in 2025, but the outlook is positive 29.58% per year for the next five years.
OM Dividends
Outset Medical Inc’s next quarterly earnings report is expected to be released in April.
AMERIPRISE FINANCIAL INC, with 10.2162% or 5.2 million shares worth $20.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Select Portfolios – Medical Technology & Devices Port and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.3 shares worth $2.4 million, making up 6.14% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.65 shares worth around $1.2 million, which represents about 3.07% of the total shares outstanding.
